DISEASE OUTCOMES AT CIRCA 36 YEARS IN HEPATITIS C VIRUS (HCV) INFECTED WOMEN IN AN IRISH ANTI-D COHORT

被引：0
|
作者：
Garvey, P. [1 ,2 ]
Thornton, L. [1 ]
Murphy, N. [1 ]
Flanagan, P. [1 ]
Norris, S. [3 ,4 ]
机构：
[1] Hlth Protect Surveillance Ctr, Dublin, Ireland
[2] ECDC, EPIET, Stockholm, Sweden
[3] St James Hosp, Hepatol Unit, Dublin, Ireland
[4] Trinity Coll Dublin, Sch Med, Dublin, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2016年 / 185卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：557 / 557
页数：1
相关论文
共 50 条
  • [31] Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in Baghdad
    Al-Kubaisy, Waqar
    Daud, Suzanna
    Al-Kubaisi, Mustafa Waseem
    Al-Kubaisi, Omar Waseem
    Abdullah, Nik Nairan
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (20): : 3464 - 3469
  • [32] Mortality in hepatitis C virus (HCV) infected blood donors: A large, retrospective cohort study
    Murphy, L.
    VOX SANGUINIS, 2006, 91 : 14 - 14
  • [33] Mortality in hepatitis C virus (HCV) infected former blood donors: A retrospective cohort study
    Guiltinan, A
    Kaidarova, Z
    Orland, J
    Strollo, A
    Cyrus, S
    Busch, MP
    Murphy, EL
    TRANSFUSION, 2005, 45 (03) : 9A - 9A
  • [34] Evaluation of Liver Disease Progression in the German Hepatitis C Virus (1b)-Contaminated Anti-D Cohort at 35 Years After Infection (vol 59, pg 49, 2014)
    Wiese, Manfred
    Fischer, Janctt
    Loebermann, Micha
    Goebel, Uwe
    Gruengreiff, Kurt
    Guethoff, Wolfgang
    Kullig, Ulrike
    Richter, Franziska
    Schiefke, Ingolf
    Tenckhoff, Hannelore
    Zipprich, Alexander
    Berg, Thomas
    Mueller, Tobias
    HEPATOLOGY, 2015, 61 (04) : 1446 - 1447
  • [35] Evaluation of a model of adjustment in a group of Irish women with an iatrogenic hepatitis C virus (HCV) infection.
    Coughlan, BM
    Sheehan, J
    Carr, A
    Bunting, B
    Crowe, J
    HEPATOLOGY, 2001, 34 (04) : 688A - 688A
  • [36] Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
    Kenny-Walsh, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16): : 1228 - 1233
  • [37] Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation
    Lawlor, E
    Power, J
    Garson, JA
    Yap, PL
    Davidson, F
    Columb, G
    Smith, D
    Pomeroy, L
    O'Riordan, J
    Simmonds, P
    Tedder, RS
    VOX SANGUINIS, 1999, 76 (03) : 138 - 143
  • [38] Serum ALT is not predictive of histological response to interferon in ANTI-D infected hepatitis C patients.
    McKiernan, S
    Pilkington, R
    McDonald, G
    Kelleher, D
    GASTROENTEROLOGY, 1997, 112 (04) : A1331 - A1331
  • [39] Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
    Lawlor, E
    Columb, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10): : 762 - 762
  • [40] MOLECULAR EPIDEMIOLOGY OF AN OUTBREAK OF INFECTION WITH HEPATITIS-C VIRUS IN RECIPIENTS OF ANTI-D IMMUNOGLOBULIN
    POWER, JP
    LAWLOR, E
    DAVIDSON, F
    HOLMES, EC
    YAP, PL
    SIMMONDS, P
    LANCET, 1995, 345 (8959): : 1211 - 1213
12345